Cargando…
Regression of portal hypertension: underlying mechanisms and therapeutic strategies
Portal hypertension is the main non-neoplastic complication of chronic liver disease, being the cause of important life-threatening events including the development of ascites or variceal bleeding. The primary factor in the development of portal hypertension is a pathological increase in the intrahe...
Autores principales: | Selicean, Sonia, Wang, Cong, Guixé-Muntet, Sergi, Stefanescu, Horia, Kawada, Norifumi, Gracia-Sancho, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886770/ https://www.ncbi.nlm.nih.gov/pubmed/33544313 http://dx.doi.org/10.1007/s12072-021-10135-4 |
Ejemplares similares
-
Mechanobiology of portal hypertension
por: Felli, Eric, et al.
Publicado: (2023) -
Advances in therapeutic options for portal
hypertension
por: Vilaseca, Marina, et al.
Publicado: (2018) -
Emerging Therapeutic Targets for Portal Hypertension
por: Felli, Eric, et al.
Publicado: (2023) -
4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers
por: Fernández‐Iglesias, Anabel, et al.
Publicado: (2018) -
Nuclear deformation mediates liver cell mechanosensing in cirrhosis
por: Guixé-Muntet, Sergi, et al.
Publicado: (2020)